Skip to main content
. Author manuscript; available in PMC: 2023 Apr 20.
Published in final edited form as: J Med Chem. 2021 Dec 15;64(24):18025–18053. doi: 10.1021/acs.jmedchem.1c01382

Figure 7.

Figure 7.

Antiproliferative activity of candidate compound 44e relies on BRD4 and CK2. (A) BRD4, CK2, or BRD4/CK2 knockdown efficiency in MDA-MB-231 cells as determined by Western blots. GAPDH was used as a control. (B) MDA-MB-231 cell viability after 24 h at different concentrations of 44e.